Clinical trial Recruiting at 1 site Interventional Ages 10 to 17

Adding basic body awareness therapy to scoliosis-specific exercises for teens with scoliosis

Official title: Effects of Integrating Basic Body Awareness Therapy Into Scoliosis-Specific Exercises on Body Awareness, Quality of Life, and Scoliosis-Related Outcomes in Adolescents With Idiopathic Scoliosis: A Randomized Controlled Trial

Run by Hacettepe University · NCT07500883 · Data updated 2026-11-12

This test will see if adding Basic Body Awareness Therapy to scoliosis-specific exercises helps teens (ages 10–17) with adolescent idiopathic scoliosis improve body awareness, trunk control, and quality of life.

Quick facts

Study typeInterventional
Ages10 Years to 17 Years
SexAll
Enrollment40 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara, Ankara)
StatusRecruiting
StartedNovember 12, 2025
Main results expectedApril 2026
Study endsApril 2026
Registry record updatedMarch 30, 2026
Trial IDNCT07500883 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 10–17 with adolescent idiopathic scoliosis, a Cobb angle of at least 15°, Risser sign 0–4, and no prior bracing or surgery.

Probably not a fit

Patients with congenital or neuromuscular scoliosis, prior orthosis or spinal surgery, significant medical comorbidities, or regular high-level sports participation are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares scoliosis-specific physiotherapeutic exercises (PSSE) alone versus PSSE plus Basic Body Awareness Therapy (BBAT) in adolescents with idiopathic scoliosis. Eligible participants are 10–17 years old with a Cobb angle ≥15° and Risser 0–4, with no prior scoliosis treatment, and are randomized to receive the two different rehabilitation approaches. Outcomes include measures of body awareness, trunk proprioception, scoliosis-specific clinical parameters, and health-related quality of life. The single-center trial is conducted at Hacettepe University Faculty of Physical Therapy and Rehabilitation in Ankara.

Why it matters

Potential benefit: If successful, the combined approach could give adolescents a noninvasive way to improve body awareness, postural control, and quality of life alongside standard scoliosis exercises.

How similar studies have gone: Physiotherapeutic scoliosis-specific exercises have demonstrated benefits for spinal alignment and function, but combining them with BBAT is relatively novel and direct evidence for BBAT in AIS is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed of adolescent idiopathic scoliosis
* Age between 10 and 17 years
* Cobb angle ≥15°
* No previous or concurrent scoliosis treatment
* Risser sign between 0 and 4

Exclusion Criteria:

* Evidence of congenital scoliosis or other spinal deformities (e.g., hyperkyphosis, pectus deformities)
* Diagnosis of neuromuscular, rheumatologic, neurological, cardiovascular, pulmonary disorders
* Regular participation in sports
* History of spinal orthosis use or scoliosis surgery.

Where it's running

  • Hacettepe University Faculty of Physical Therapy and Rehabilitation, Orthotics and Biomechanics Clinic
    Ankara, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.